MONMOUTH JUNCTION, N.J., Dec. 12, 2016 /PRNewswire/ — CytoSorbents Company, a vital treatment immunotherapy chief commercializing its flagship CytoSorb® bloodstream filtration to deal with lethal…
source http://www.cert-world.com/cytosorbents-receives-318551-in-non-dilutive-funding-from-the-new-jersey-technology-business-tax-certificate-transfer-program/
No comments:
Post a Comment